A tale of two viruses: Hepatitis C in the age of HAART

Lancet

Volumn 362, Issue 9397, 2003, Pages 1687-1688

  Alatrakchi, Nadia ^a   Koziel, Margaret James ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

CELLULAR IMMUNITY; EUROPE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INCIDENCE; INFECTION RISK; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER TOXICITY; LYMPHOCYTE COUNT; MORTALITY; NOTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE; UNITED STATES; VIRUS TRANSMISSION;

EID: 0344552446     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14881-7     Document Type: Note

References (15)

1. Bica I., McGovern B., Dhar R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 32:2001;492-497.
2. Armstrong G.L., Alter M.J., McQuillan G.M., Margolis H.S. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology. 31:2000;777-782.
3. Graham C.S., Baden L.R., Yu E., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 33:2001;562-569.
4. Benhamou Y., Bochet M., Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients: the Multivirc Group. Hepatology. 30:1999;1054-1058.
5. Sulkowski M.S., Thomas D.L., Chaisson R.E., Moore R.D. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 283:2000;74-80.
6. den Brinker M., Wit F.W., Wertheim-van Dillen P.M., et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS. 14:2000;2895-2902.
7. Nunez M., Lana R., Mendoza J.L., Martin-Carbonero L., Soriano V. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 27:2001;426-431.
8. Aceti A., Pasquazzi C., Zechini B., De Bac C. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV-1: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr. 29:2002;41-48.
9. Einav S., Koziel M. Immunopathogenesis of hepatitis C virus in the immunosuppressed host. Transpl Infect Dis. 4:2002;85-92.
10. Martin-Carbonero L., Nunez M., Rios P., Perez-Olmeda M., Gonzalez-Lahoz J., Soriano V. Liver injury after beginning antiretroviral therapy in HIV-1/hepatitis C virus co-infected patients is not related to immune reconstitution. AIDS. 16:2002;1423-1425.
11. Martinez-Sierra C., Arizcorreta A., Diaz F., et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 36:2003;491-498.
12. Tedaldi E.M., Baker R.K., Moorman A.C., et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 36:2003;363-367.
13. Macias J., Melguizo I., Fernandez-Rivera F.J., et al. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-1-infected patients receiving potent antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 21:2002;775-781.
14. Babik J.M., Holodniy M. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients. J Virol. 77:2003;1940-1950.
15. Ghany M.G., Kleiner D.E., Alter H., et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology. 124:2003;97-104.